Emergent Pharmaceutical Treatments for Dry Ey...

In this episode, Robert J. Noecker, MD, reviews the role of preservatives, particularly benzalkonium chloride (BAK), in ophthalmic medications. While BAK effectively prevents bacterial growth, its inherent toxicity poses challenges with prolonged use, leading to symptoms associat ...  Show more

In this episode, Miriam Kolko, MD, PhD, shares her vision for preservative-free eye care. Dr. Kolko strongly advocates for patient education regarding the benefits and limitations of preservative-free alternatives, encouraging tailored treatment strategies. Ultimately, she envisi ...  Show more

This final podcast of three dedicated to dry eye disease (DED) brings together Prof. Stefano Barabino (Italy), Prof. Marc Labetoulle (France) and Rebecca Petris (USA) to discuss DED from the patient’s perspective. Rebecca, founder of the patient organization The Dry Eye Foundatio ...  Show more

The impact of severe ​​dry eye or ocular surface disease on quality of life has been compared to someone who’s had a renal transplant or unstable angina. In this episode, we hear how dry eye disease affected both the ocular and mental health of patient Dave Cannell. For optometri ...  Show more

In this episode, experts in administrative support join Brandon D. Ayres, MD, to discuss their role in facilitating patient treatment for keratoconus. Susan DeGroot, MBA, executive director at Vance Thompson Vision, and Vivian Cole, BA, director of administrative services at Hori ...  Show more

In this episode of CRST: The Podcast, host Kenneth Beckman, MD, FACS, speaks with Priya M. Mathews, MD, MPH, about the critical role of dry eye management in cataract surgery. They discuss the importance of optimizing the ocular surface before surgery to ensure premium outcomes, ...  Show more